MentionFox
Home › Who owns › Virax Biolabs Group Ltd
Owners, funding and legal record

Who owns Virax Biolabs Group Limited? Owners, funding and legal record

Before you sign with, sell to or invest in Virax Biolabs Group Ltd

MentionFox check on Virax Biolabs Group Ltd: no red flags found in 10 sources (checked 6 November 2026). mentionfox.com/c/who-owns/virax-biolabs

Check Virax Biolabs Group Ltd before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Virax Biolabs Group Ltd?

Virax Biolabs Group Ltd is a publicly traded company (Nasdaq: VRAX). The most recent 5%+ ownership report names Armistice Capital holding 9.99% (Schedule 13G, filed 2026-02-17).

As of November 6, 2026, Virax Biolabs Group Ltd is a publicly traded company (Nasdaq: VRAX). The largest insider holding is Foster James Alexander Cunliffe, the chief executive, with 287,987 shares (49.7% of shares outstanding), per Form 3 of March 18, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings (Schedule 13G, February 17, 2026).

Armistice Capital, LLC also filed stake reports on 120 other companies ↓

Is this your company?

About to sign with, pay or invest in Virax Biolabs Group Limited? See the free Snapshot first.

Watch Virax Biolabs Group Limited

Free to see. No signup.

Is Virax Biolabs Group Ltd a real, registered company?

Before you sign or pay

Who are Virax Biolabs Group Ltd's owners and officers?

Virax Biolabs Group Ltd: business address in Lanarkshire, X0; industry In Vitro & In Vivo Diagnostic Substances (Schedule 13G/A, 2026-05-15).

Officers and directors, each with the role and the filing that names them:

ReportHolderShare
Schedule 13G/A, 2026-05-15Armistice Capital, LLC4.99%
Schedule 13G, 2026-02-17Armistice Capital, LLC9.99%
Schedule 13G, 2025-10-29James Foster24.9%
Schedule 13G/A, 2025-10-29James Foster8.3%
Schedule 13G/A, 2025-10-29James Foster12.9%
Schedule 13G/A, 2025-10-29James Foster7.3%

Questions about who owns Virax Biolabs Group Ltd

Who owns Virax Biolabs Group Ltd?

On this page, one holder's latest ownership filing reports 5% or more of Virax Biolabs Group Ltd: James Foster (24.9%, Schedule 13G, filed 2025-10-29).

When did James Foster buy into Virax Biolabs Group Ltd?

The filings give report dates, not purchase dates. The earliest filing from James Foster on this page is the Schedule 13G, filed 2025-10-29, reporting 24.9%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 6 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Virax Biolabs Group Limited?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Virax Biolabs Group Limited: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Virax Biolabs Group Limited covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    11 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Virax Biolabs Group Ltd shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 579,218 as of 2026-03-31, from the company's latest SEC cover page.

How much has Virax Biolabs Group Ltd raised?

FiledSoldOffered
Form D, 2025-12-18$5M$5M
Form D, 2023-10-17$2.15M$2.15M
Form D, 2023-03-15$4M$4M

Keep reading

More on Virax Biolabs Group Limited and the records around it.

Virax Biolabs Group Limited elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/virax-biolabs
Last updated 2026-11-06
Who owns Virax Biolabs Group Limited? Owners, funding and legal record. MentionFox, 2026-11-06. https://mentionfox.com/who-owns/virax-biolabs